3-52390959-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015512.5(DNAH1):āc.9646C>Gā(p.Leu3216Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00119 in 1,552,314 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_015512.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH1 | NM_015512.5 | c.9646C>G | p.Leu3216Val | missense_variant | 61/78 | ENST00000420323.7 | NP_056327.4 | |
DNAH1 | XM_017006129.2 | c.9715C>G | p.Leu3239Val | missense_variant | 63/80 | XP_016861618.1 | ||
DNAH1 | XM_017006130.2 | c.9646C>G | p.Leu3216Val | missense_variant | 62/79 | XP_016861619.1 | ||
DNAH1 | XM_017006131.2 | c.9589C>G | p.Leu3197Val | missense_variant | 62/79 | XP_016861620.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH1 | ENST00000420323.7 | c.9646C>G | p.Leu3216Val | missense_variant | 61/78 | 1 | NM_015512.5 | ENSP00000401514 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000749 AC: 114AN: 152224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000666 AC: 106AN: 159132Hom.: 0 AF XY: 0.000608 AC XY: 51AN XY: 83844
GnomAD4 exome AF: 0.00124 AC: 1736AN: 1399972Hom.: 1 Cov.: 32 AF XY: 0.00121 AC XY: 838AN XY: 690540
GnomAD4 genome AF: 0.000748 AC: 114AN: 152342Hom.: 0 Cov.: 33 AF XY: 0.000792 AC XY: 59AN XY: 74506
ClinVar
Submissions by phenotype
Spermatogenic failure 18;C4539798:Ciliary dyskinesia, primary, 37 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2022 | This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 3216 of the DNAH1 protein (p.Leu3216Val). This variant is present in population databases (rs200158571, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with DNAH1-related conditions. ClinVar contains an entry for this variant (Variation ID: 478516). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DNAH1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Primary ciliary dyskinesia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | UNC Molecular Genetics Laboratory, University of North Carolina at Chapel Hill | Apr 18, 2019 | - - |
Oligosynaptic infertility;C4539798:Ciliary dyskinesia, primary, 37 Other:1
not provided, no classification provided | phenotyping only | GenomeConnect - Invitae Patient Insights Network | - | Variant interpreted as Uncertain significance and reported on 06-08-2020 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at